|
|
Post by mnholdem on Oct 29, 2015 12:57:23 GMT -5
Many biotech stocks in my portfolio or on my watchlist are in the red today:
ISIS -0.7% INO -0.9% NWBO -0.9% CARA -1.8% ZIOP -1.76% HALO -3.02% NVAX -3.27% XON -4.5% NLNK -4.78% MNKD -5.69% EXAS -7.85%
ACAD is +0.08% SGMO is +11.83% following CEO Edward Lanphier comments at yesterday's Q3 2015 earnings call.
----
Obviously, our partner's earnings call didn't result in stellar results for Afrezza, but I wish folks would calm down a bit. Sanofi's treatment of Afrezza is not the primary reason why the share price is down today.
|
|
|
|
Post by peppy on Oct 29, 2015 13:36:32 GMT -5
Europe closed, and mnkd selling.
drat.
|
|
|
|
Post by babaoriley on Oct 29, 2015 13:43:59 GMT -5
Many biotech stocks in my portfolio or on my watchlist are in the red today:
ISIS -0.7% INO -0.9% NWBO -0.9% CARA -1.8% ZIOP -1.76% HALO -3.02% NVAX -3.27% XON -4.5% NLNK -4.78% MNKD -5.69% EXAS -7.85%
ACAD is +0.08% SGMO is +11.83% following CEO Edward Lanphier comments at yesterday's Q3 2015 earnings call.
----
Obviously, our partner's earnings call didn't result in stellar results for Afrezza, but I wish folks would calm down a bit. Sanofi's treatment of Afrezza is not the primary reason why the share price is down today.
Hate to disagree with you, Mnholdem, but today's SNY call was a market mover for MNKD. Edward's a great speaker, I'll try to listen tonight. But SGMO sure has been weak lately. And don't even tell me about EXAS, what a giant disappointment that turned into recently. |
|
|
|
Post by EveningOfTheDay on Oct 29, 2015 13:44:29 GMT -5
It looks like whoever said that shorts were waiting for SNYs and MNKDs earnings calls to play their yoyo games again had it right.
|
|
|
|
Post by novafett on Oct 29, 2015 13:49:22 GMT -5
Down almost 12%  |
|
|
|
Post by EveningOfTheDay on Oct 29, 2015 13:54:24 GMT -5
12% and counting.
|
|
|
|
Post by jpg on Oct 29, 2015 13:57:05 GMT -5
Novo is down over 6% and Sanofi over 3%. The diabetic space is getting hurt. Mannkind down 12%. Whatever and does it really matter? It's all trading noise. Diabetes isn't going away!
|
|
|
|
Post by dreamboatcruise on Oct 29, 2015 13:57:24 GMT -5
"Calm down - many biotech stocks are getting hammered today" Ahhhhh!... SNY's comments about Afrezza were so bad it's taking down the entire sector!!! Ahhhh!!! Is that what you mean by being calm? Sorry, just kidding      |
|
|
|
Post by novafett on Oct 29, 2015 14:02:02 GMT -5
Agreed.. been looking for a chance to buy another $1000. A pittance for most of you but i'm dabbling and having fun  |
|
|
|
Post by mdcenter61 on Oct 29, 2015 14:06:53 GMT -5
Agreed.. been looking for a chance to buy another $1000. A pittance for most of you but i'm dabbling and having fun
I like your attitude, novafett, but I'm sure not having any fun today! 
|
|
|
|
Post by rrtzmd on Oct 29, 2015 14:12:45 GMT -5
Many biotech stocks in my portfolio or on my watchlist are in the red today:
ISIS -0.7% INO -0.9% NWBO -0.9% CARA -1.8% ZIOP -1.76% HALO -3.02% NVAX -3.27% XON -4.5% NLNK -4.78% MNKD -5.69% EXAS -7.85%
ACAD is +0.08% SGMO is +11.83% following CEO Edward Lanphier comments at yesterday's Q3 2015 earnings call.
----
Obviously, our partner's earnings call didn't result in stellar results for Afrezza, but I wish folks would calm down a bit. Sanofi's treatment of Afrezza is not the primary reason why the share price is down today.
Down 16.4% at 3:10 and that is one ugly chart. Looks like it just jumped off a cliff at 2:30. |
|
|
|
Post by EveningOfTheDay on Oct 29, 2015 14:13:24 GMT -5
Novo is down over 6% and Sanofi over 3%. The diabetic space is getting hurt. Mannkind down 12%. Whatever and does it really matter? It's all trading noise. Diabetes isn't going away! Well, I don't think the whole 12% 16% 18% back to 12% now (which in comparison looks even good) 8% (feels like a positive) was sector specific.Although, I agree with you, at this point in time, it does not matter, I too am starting to wonder when it will start mattering. I have my own game plan and time projections, and I want to see it played out, so for the time being I am not going anywhere. However, I can not in good faith say I am not annoyed about how the whole game is being played, and, in days like today, equally annoyed about the lack of empathy towards MNKD investors from both SNY and MNKD management, which, in theory, must have known exactly what SNY would say, and do little, at least in appearance, to soften the blow. Of course there is the argument to be made of whether they could actually say something to soften the blow, or anything they say would have made it worst. Based on recent history one could easily argue the latter would be more likely. |
|
|
|
Post by miracle331 on Oct 29, 2015 14:16:33 GMT -5
lol 18%...
|
|
|
|
Post by jpg on Oct 29, 2015 14:18:00 GMT -5
It called a bear raid...
An effective one at that!
|
|
|
|
Post by scottiemac on Oct 29, 2015 14:23:07 GMT -5
This too shall pass. This is the kind of day I turn off the computer and do something useful, and calming, like carving pumpkins. I remind myself there are so many people (including some of my own siblings) who have much bigger problems with health or finances or both. MNKD is only a small percentage of my assets, I have a roof over my head, food on the table, a loving spouse of 35 years, and reasonably good health. Would I prefer we were going UP 18+% rather than down - hell yeah. But in the greater scheme of things I've experienced over 60+ years it's a bump in the road. Been investing since 1980; this is background noise.  |
|
